Pharmafile Logo
Pharmafocus logo
Advanced Search
julian_seward

New managing director for PM Devereux

April 16, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Julian Seward, PM Devereux

Healthcare, science and technology architectural firm PM Devereux has confirmed the appointment of Julian Seward as a managing director. Seward …

Appointment

Pfizer breast cancer trial stopped following promising results

April 15, 2015
Sales and Marketing ASCO, FDA, Pfizer, ibrance, palbociclib

Regulators have stopped a Phase III clinical trial of Pfizer’s Ibrance early after it demonstrated improved survival in women with …

News
arzerra image

Trial results back NICE decision on Novartis cancer drug

April 15, 2015
Sales and Marketing Arzerra, Cancer, NHS, NICE, chemo, chlorambucil, fludarabine, leukaemia, ofatumumab

Treatment with Arzerra improves survival in people with chronic lymphocytic leukaemia (CLL) according to study results that back NICE’s decision …

News
udit_batra

Merck hires life sciences business head

April 15, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck, Merck Millipore, Sigma-Aldrich, udit batra

Merck has confirmed that the current chief executive and president of Merck Millipore Dr Udit Batra has been appointed to lead …

Appointment
astrazeneca image

FDA grants AstraZeneca immune drug orphan status

April 15, 2015
Sales and Marketing AstraZeneca, FDA, Iressa, MEDI4736, MedImmune, NSCLC, US, gefitinib, non-small cell lung cancer, tremelimumab

The US Food and Drug Administration has granted orphan drug designation to AstraZeneca’s anti-CTLA-4 monoclonal antibody tremelimumab for the treatment …

News
FDA image

AZ and Takeda diabetes drugs get FDA safety update

April 15, 2015
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, diabetes, saxagliptin

An FDA advisory committee has said that the labels of two type 2 diabetes drugs should be changed to warn …

News
J&J image

J&J strong pharma sales can’t offset Q1 losses

April 15, 2015
Sales and Marketing J&J, JJ, Q1, Waldenström's macroglobulinemia, Waldenström’s Macroglobulinemia, Zytiga, abiraterone acetate, financials, ibrutinib, imbruvica

Johnson & Johnson’s pharma division achieved worldwide sales of $7.7 billion in the first quarter of this year – but …

News
oliver_albrecht_

Vetter confirms new managing director

April 15, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oliver Albrecht, Vetter

German contract development and manufacturing organisation Vetter has appointed Oliver Albrecht as a managing director. Albrecht replaces Max Horn in …

Appointment

World Health Organisation calls for full trial transparency

April 14, 2015
Research and Development, Sales and Marketing Ben Goldacre, EU, WHO, World Health Organisation, alltrials, clinical trials, sense about science, transparency

The World Health Organization has thrown its weight behind clinical trial transparency in a new statement on its position. WHO …

News
J&J image

IBM partners with J&J, Apple and Medtronics ‘to transform healthcare’

April 14, 2015
Sales and Marketing Apple, J&J, JJ, ibm, medtronics

IT firm IBM has teamed up with pharma giants and tech companies to expand its presence in the health and …

News
Astrazeneca image

AstraZeneca partners with PatientsLikeMe

April 14, 2015
Sales and Marketing AstraZeneca, Lupus, PatientsLikeMe, Roche, diabetes, oncology, respiratory disease

AstraZeneca has signed a five-year agreement with PatientsLikeMe to give the pharma firm access to the latter’s global network of …

News
Sanofi image

Sanofi rules out Toujeo discount in diabetes

April 14, 2015
Sales and Marketing 100 U/mL, Boehringer, Lantus, insulin glargine [rDNA origin] injection, lilly, toujeo

Sanofi has revealed that it will not discount its new insulin Toujeo more than its current blockbuster Lantus, despite lacking …

News

US drug spend soars to all-time high in 2014

April 14, 2015
Manufacturing and Production, Sales and Marketing Lipitor, Obama, UK Health and Social Care Information Centre, US, drug spend, prescribing

The number of prescriptions dispensed in the US rose by 13% in 2014 a new report has shown. The increase …

News

Manufacturing woes hit Baxter again

April 14, 2015
Manufacturing and Production, Sales and Marketing FDA, Gemünden, Pfizer, alesse, baxter, manufacturing, recall, vectura group

Baxter is voluntarily recalling several lots of intravenous solutions due to the potential presence of particulate matter.  The news has …

News
colin_watson

Ashfield Healthcare names new UK managing director

April 14, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield, colin watson

Ashfield Healthcare has appointed Colin Watson as its managing director for the UK, taking over from Enda Scott who has …

Appointment

Cancer Research Technology and Medivir to develop new class of cancer drugs

April 13, 2015
Research and Development, Sales and Marketing Medivir, UK, adam8, cancer research technology, oncology

Cancer Research Technology and Medivir will join forces to develop a new class of drugs that has shown promise for …

News
Apple watch

Most anticipated health wearable lands shortly

April 13, 2015
Medical Communications, Sales and Marketing Apple, digital, research kit, smartwatch, watch, wearable, wearables

Consumers can order Apple’s eagerly anticipated watch now as the industry waits to see just what impact it could have …

News
Novartis image

Novartis to highlight Gilenya data at neurology congress

April 13, 2015
Sales and Marketing American Academy of Neurology, Novartis, fingolimod, gilenya

Novartis will be highlighting data for its multiple sclerosis drug Gilenya at this year’s American Academy of Neurology (AAN) annual …

News
Keytruda image

Drug development showcasing at AACR conference

April 13, 2015
Research and Development, Sales and Marketing American Association of Cancer Research, AstraZeneca, Bayer, Genentech, Novartis, aacr

This month’s American Association of Cancer Research conference is set to showcase the latest studies in oncology. Roche’s biotech subsidiary …

News
Astrazeneca image

AstraZeneca diabetes drug could ‘significantly’ increase mortality

April 13, 2015
Research and Development, Sales and Marketing AstraZeneca, FDA, Nesina, Onglyza, Takeda, alogliptin, cardiovascular, saxagliptin

AstraZeneca’s diabetes drug Onglyza may lead to a ‘significant increase’ in risk of death according to a new analysis from …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026